Tyler E. Gaston

1.7k total citations
36 papers, 1.2k citations indexed

About

Tyler E. Gaston is a scholar working on Psychiatry and Mental health, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Tyler E. Gaston has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Psychiatry and Mental health, 21 papers in Pharmacology and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Tyler E. Gaston's work include Epilepsy research and treatment (24 papers), Cannabis and Cannabinoid Research (21 papers) and Psychosomatic Disorders and Their Treatments (9 papers). Tyler E. Gaston is often cited by papers focused on Epilepsy research and treatment (24 papers), Cannabis and Cannabinoid Research (21 papers) and Psychosomatic Disorders and Their Treatments (9 papers). Tyler E. Gaston collaborates with scholars based in United States, Canada and Netherlands. Tyler E. Gaston's co-authors include Jerzy P. Szaflarski, Daniel Friedman, Gary Cutter, E. Martina Bebin, Yuliang Liu, Leslie E. Grayson, Jane B. Allendorfer, Kathleen Hernando, Steve Ampah and E. Martina Bebin and has published in prestigious journals such as Neurology, Annals of Neurology and Brain Research.

In The Last Decade

Tyler E. Gaston

35 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tyler E. Gaston United States 17 794 606 402 178 117 36 1.2k
William Notcutt United Kingdom 14 1.4k 1.7× 242 0.4× 504 1.3× 290 1.6× 169 1.4× 26 1.8k
Valentina Franco Italy 20 316 0.4× 620 1.0× 360 0.9× 107 0.6× 487 4.2× 56 1.2k
Divya Ramesh United States 17 1.2k 1.5× 88 0.1× 555 1.4× 229 1.3× 76 0.6× 34 1.4k
Amina M. Bagher Saudi Arabia 14 1.1k 1.4× 81 0.1× 649 1.6× 208 1.2× 73 0.6× 44 1.6k
Jan M. Keppel Hesselink Germany 21 314 0.4× 122 0.2× 174 0.4× 84 0.5× 101 0.9× 98 1.2k
Eric P. Baron United States 12 468 0.6× 230 0.4× 69 0.2× 74 0.4× 82 0.7× 17 758
Martin Schnelle Germany 7 611 0.8× 67 0.1× 178 0.4× 112 0.6× 82 0.7× 8 818
Ahmet Doğrul Türkiye 27 544 0.7× 102 0.2× 831 2.1× 131 0.7× 65 0.6× 79 2.1k
Erin M. Rock Canada 21 1.2k 1.5× 77 0.1× 377 0.9× 339 1.9× 80 0.7× 55 1.4k
Sonja Vučković Serbia 17 292 0.4× 85 0.1× 298 0.7× 60 0.3× 66 0.6× 75 1.0k

Countries citing papers authored by Tyler E. Gaston

Since Specialization
Citations

This map shows the geographic impact of Tyler E. Gaston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tyler E. Gaston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tyler E. Gaston more than expected).

Fields of papers citing papers by Tyler E. Gaston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tyler E. Gaston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tyler E. Gaston. The network helps show where Tyler E. Gaston may publish in the future.

Co-authorship network of co-authors of Tyler E. Gaston

This figure shows the co-authorship network connecting the top 25 collaborators of Tyler E. Gaston. A scholar is included among the top collaborators of Tyler E. Gaston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tyler E. Gaston. Tyler E. Gaston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Szaflarski, Jerzy P., W. Curt LaFrance, Rodolphe Nenert, et al.. (2025). Neurobehavioral therapy in functional seizures: Investigation of mechanism of action with resting‐state functional magnetic resonance imaging. Epilepsia. 66(8). 2881–2893. 1 indexed citations
2.
3.
Patten, Ryan Van, Andrew S. Blum, Stephen Correia, et al.. (2024). One‐year follow‐up of neurobehavioral therapy in functional seizures or epilepsy with traumatic brain injury: A nonrandomized controlled trial. Epilepsia. 65(12). 3545–3560. 5 indexed citations
4.
Patten, Ryan Van, Kristen Mordecai, Hamada Altalib, et al.. (2023). Improvements in Montreal Cognitive Assessment scores after neurobehavioral therapy in adults with functional (nonepileptic) seizures and traumatic brain injury. Journal of Psychiatric Research. 165. 282–289. 5 indexed citations
5.
Mueller, Christina, Adam M. Goodman, Jane B. Allendorfer, et al.. (2023). White Matter Changes after Neurobehavioral Therapy for Functional Seizures. Annals of Neurology. 94(2). 350–365. 12 indexed citations
6.
7.
Gaston, Tyler E., Roy C. Martin, & Jerzy P. Szaflarski. (2021). Cannabidiol (CBD) and cognition in epilepsy. Epilepsy & Behavior. 124. 108316–108316. 10 indexed citations
8.
Houston, James T, Rodolphe Nenert, Jane B. Allendorfer, et al.. (2021). White matter integrity after cannabidiol administration for treatment resistant epilepsy. Epilepsy Research. 172. 106603–106603. 5 indexed citations
9.
Gaston, Tyler E., Steve Ampah, E. Martina Bebin, et al.. (2021). Long-term safety and efficacy of highly purified cannabidiol for treatment refractory epilepsy. Epilepsy & Behavior. 117. 107862–107862. 30 indexed citations
10.
Grayson, Leslie E., Steve Ampah, Kathleen Hernando, et al.. (2021). Longitudinal impact of cannabidiol on EEG measures in subjects with treatment-resistant epilepsy. Epilepsy & Behavior. 122. 108190–108190. 11 indexed citations
11.
Goodman, Adam M., Jane B. Allendorfer, Andrew S. Blum, et al.. (2020). White matter and neurite morphology differ in psychogenic nonepileptic seizures. Annals of Clinical and Translational Neurology. 7(10). 1973–1984. 28 indexed citations
12.
Gaston, Tyler E., Jane B. Allendorfer, E. Martina Bebin, et al.. (2020). Effects of highly purified cannabidiol (CBD) on fMRI of working memory in treatment-resistant epilepsy. Epilepsy & Behavior. 112. 107358–107358. 11 indexed citations
13.
Gaston, Tyler E., Donna L. Mendrick, Mary F. Paine, Amy L. Roe, & Catherine K. Yeung. (2020). “Natural” is not synonymous with “Safe”: Toxicity of natural products alone and in combination with pharmaceutical agents. Regulatory Toxicology and Pharmacology. 113. 104642–104642. 59 indexed citations
14.
Gaston, Tyler E., E. Martina Bebin, Gary Cutter, et al.. (2019). Drug–drug interactions with cannabidiol (CBD) appear to have no effect on treatment response in an open-label Expanded Access Program. Epilepsy & Behavior. 98(Pt A). 201–206. 35 indexed citations
15.
Allendorfer, Jane B., Rodolphe Nenert, E. Martina Bebin, et al.. (2019). fMRI study of cannabidiol-induced changes in attention control in treatment-resistant epilepsy. Epilepsy & Behavior. 96. 114–121. 32 indexed citations
16.
Gaston, Tyler E., Magdalena Szaflarski, Barbara Hansen, E. Martina Bebin, & Jerzy P. Szaflarski. (2019). Quality of life in adults enrolled in an open-label study of cannabidiol (CBD) for treatment-resistant epilepsy. Epilepsy & Behavior. 95. 10–17. 33 indexed citations
17.
Gaston, Tyler E., et al.. (2017). Interactions between cannabidiol and commonly used antiepileptic drugs. Epilepsia. 58(9). 1586–1592. 255 indexed citations
18.
Gaston, Tyler E. & Daniel Friedman. (2017). Pharmacology of cannabinoids in the treatment of epilepsy. Epilepsy & Behavior. 70(Pt B). 313–318. 150 indexed citations
19.
Wissel, Benjamin D., Alok Dwivedi, Tyler E. Gaston, et al.. (2016). Which patients with epilepsy are at risk for psychogenic nonepileptic seizures (PNES)? A multicenter case–control study. Epilepsy & Behavior. 61. 180–184. 25 indexed citations
20.
Allendorfer, Jane B., Tyler E. Gaston, Joseph C. Griffis, et al.. (2015). White matter diffusion abnormalities in patients with psychogenic non-epileptic seizures. Brain Research. 1620. 169–176. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William Notcutt Breakdown of academic impact, for papers by Valentina Franco Breakdown of academic impact, for papers by Divya Ramesh Breakdown of academic impact, for papers by Amina M. Bagher Breakdown of academic impact, for papers by Jan M. Keppel Hesselink Breakdown of academic impact, for papers by Eric P. Baron Breakdown of academic impact, for papers by Martin Schnelle Breakdown of academic impact, for papers by Ahmet Doğrul Breakdown of academic impact, for papers by Erin M. Rock Breakdown of academic impact, for papers by Sonja Vučković
Rankless by CCL
2026